- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MP-10-0008930

Feliks Remedies Private Limited
About Feliks Remedies Private Limited
Data last updated:
Feliks Remedies Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2017PTC044144. Its GSTIN is 23AADCF1990N1ZE (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankit and Mohit Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 1 First Floor Neelbad Chouraha Main Market Kalkheda Road Huzur, Bhopal, Madhya Pradesh, India – 462044.
As per the financials filed for FY 2025, the company reported a revenue of ₹31,710, a decline of 92% compared to the previous year. For the same year it recorded a net loss of ₹26,090 (net margin -82.3%) and EBITDA of -₹26,090 (EBITDA margin -82.3%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 48% over five years.
Feliks Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0008930). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Feliks Remedies
Contact details
Feliks Remedies Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 1 First Floor Neelbad Chouraha Main Market Kalkheda Road Huzur, Bhopal, Madhya Pradesh, India – 462044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Feliks Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Feliks Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Feliks Remedies Private Limited, buy the company report.
Financials of Feliks Remedies Private Limited
FY 2025 filings availableFeliks Remedies Private Limited reported revenue of ₹31,710 (down 92% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 92% fall in the latest year. EBITDA fell 221% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹26,090 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26,090 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -82.3% | ||||
| Net Profit Margin | -82.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Feliks Remedies Private Limited, buy the company report.
Board of directors of Feliks Remedies Private Limited
Feliks Remedies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit | Director | 12 Sep 2017 | 9 Years 1 Months | Current |
| Mohit Tiwari | Director | 27 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Feliks Remedies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Om Vanijyaprivate Limited | ₹31,787 (FY 2023) | -96.0% | Kolkata, West Bengal, India | |||
| Jerkyy Freshfood Private Limited | ₹31,781 (FY 2025) | 84.0% | New Delhi, Delhi, India | |||
| Rosco Impex Private Limited | ₹31,750 (FY 2025) | 20.0% | Kolkata, West Bengal, India | |||
| Deepvin Pharmaceuticals Private Limited | ₹31,729 (FY 2024) | -82.0% | Lucknow, Uttar Pradesh, India | |||
| Kakkanattu Trading Company Private Limited | ₹31,717 (FY 2024) | -100.0% | Kottayam, Kerala, India | |||
| Feliks Remedies Private Limitedthis company | ₹31,710 (FY 2025) | -₹26,090 | -82.3% | -92.0% | Bhopal, Madhya Pradesh, India | |
| Hariman Global Solutions Private Limited | ₹31,700 (FY 2025) | 39.0% | Badarpur, New Delhi, Delhi, India | |||
| Yellowfellow Comforts Private Limited | ₹31,663 (FY 2021) | Karimnagar, Telangana, India | ||||
| Verstile Tie-Up Private Limited | ₹31,595 (FY 2017) | -6.0% | Kolkata, West Bengal, India | |||
| Harshal Trading Private Limited | ₹31,590 (FY 2020) | Delhi, India | ||||
| Hamsa Innovations Private Limited | ₹31,567 (FY 2025) | -73.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Feliks Remedies Private Limited, buy the company report.
Auditor
Feliks Remedies Private Limited is audited by RAVINDRA SINGH & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVINDRA SINGH & CO | FY 2019 | 016552C |
Shareholding
The shareholding of Feliks Remedies Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Feliks Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Feliks Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Feliks Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Feliks Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AADCF1990N1ZE | Madhya Pradesh | Active | 28 Nov 2017 |
To see the full GST registrations and return filing status of Feliks Remedies Private Limited, buy the company report.
Recent activity
Feliks Remedies Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Pawan Kumar Tiwari ceased to be Director on 28 Feb 2025.
Frequently asked questions
Feliks Remedies is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 September 2017 (9+ years old) and is registered under CIN U74999MP2017PTC044144.
Feliks Remedies has 2 current directors:
- Ankit - Director
- Mohit Tiwari - Director
The latest financial statements of Feliks Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Feliks Remedies is 23AADCF1990N1ZE, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Feliks Remedies is U74999MP2017PTC044144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Feliks Remedies was incorporated on 12 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Feliks Remedies by revenue are Om Vanijyaprivate Limited, Jerkyy Freshfood Private Limited, Rosco Impex Private Limited, Deepvin Pharmaceuticals Private Limited, Kakkanattu Trading Company Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Pawan Kumar Tiwari ceased to be Director on 28 Feb 2025. Mohit Tiwari was appointed as Director on 27 Feb 2025. Ankit was appointed as Director on 12 Sep 2017.
Yes, Feliks Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0008930).
The registered office of Feliks Remedies is at Shop No 1 First Floor Neelbad Chouraha Main Market Kalkheda Road Huzur, Bhopal, Madhya Pradesh, India – 462044.
Feliks Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

